Kintara Therapeutics Inc KTRA

Kintara Therapeutics Inc

Biotechnology

Healthcare

KTRA

1.69 M shares

NASDAQ US

traded

30 Oct 2023

listed

yes

open

3.93

52 week high

14.80

high

4.00

52 week low

1.32

low

3.67

growth

-6.23 %

previous Close

4.14

P/E ratio

-2

market cap

7.50 M

div yield

0

usd

Jun 2023

qoq

revenue

0.00 %

net incoming

-3.34 M

0.00 %

eps

-1.95 %

-0.52 %

eps surprise

-85.71 %

net profit margin

-333500000.00 %

0.00 %

operating incoming

-3.35 M

0.00 %

net change in cash

-1.51 M

0.00 %

cash on hand

1.54 M

0.00 %

cost of revenue

0.00 %